Erasca, Inc. - 8-K Filing

Erasca announced updated preliminary Phase 1 data for ERAS-0015 in RAS-mutant solid tumors and plans to initiate registration-enabling trials. (Items: 8.01 Other Events)

SEC EDGAR ·

Tickers: $ERAS

Read the full article at SEC EDGAR

More Regulatory news